Reverse T-stenting and Minimal Protrusion With External Minicrush for Treatment of Complex Coronary Bifurcation
NCT ID: NCT05782738
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
361 participants
INTERVENTIONAL
2023-06-01
2029-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Modified T-Stenting With Szabo Technique Versus T-Stenting for Bifurcation Lesions in Coronary Heart Diseases
NCT03714802
Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience
NCT01574586
Predilation of Side Branch During Percutaneous Treatment of Bifurcation Lesions With Provisional T Stenting
NCT01090856
A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions
NCT01186198
Smart Angioplasty Research Team-Optimal Strategy for Side Branch Stenting in Coronary Bifurcation Lesion With Drug-Coated Balloon
NCT07019350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reverse TAP
Percutaneous Coronary Intervention
Use dedicated two stents technique for treatment of coronary bifurcation stenosis
External Minicrush
Percutaneous Coronary Intervention
Use dedicated two stents technique for treatment of coronary bifurcation stenosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Percutaneous Coronary Intervention
Use dedicated two stents technique for treatment of coronary bifurcation stenosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with an indication of PCI, including Chronic Coronary syndrome (CCS) and Acute Coronary Syndrome (ACS), according to current guidelines recommendations; According to Medina and Definition criteria, patients with at least true and complex coronary lesions involved in coronary bifurcation.
Exclusion Criteria
* Patients without valid vascular access that could make unsafe PCI;
* Patients with an expected life of less than one year;
* Patients with scheduled major surgery that required prolonged DAPT interruption;
* Pregnant patients;
* Patients with DAPT contraindications.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
San Luigi Gonzaga Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enrico Cerrato
Interventional Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giulio Piedimonte, MD
Role: PRINCIPAL_INVESTIGATOR
Ospedale degli Infermi di Rivoli (TO)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ciriè Hospital
Cirié, Tori O, Italy
Ospedale Santa Croce
Moncalieri, Torino, Italy
Azienda ospedaliera Santi Antonio e Biagio e Cesare Arrigo
Alessandria, , Italy
L'Azienda Ospedaliera (AO) S. Croce e Carle
Cuneo, , Italy
Interventional Unit, San Luigi Gonzaga University Hospital, Orbassano, and Rivoli Hospital, Turin, Italy
Turin, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.